https://es.marketscreener.com/cotizacion/accion/BEYONDSPRING-INC-34241928/noticia/BeyondSpring-Inc-Inscribe-al-primer-paciente-en-un-estudio-de-fase-2-con-plinabulina-keytruda-y-do-43148165/?utm_source=telegram&utm_medium=social&utm_campaign=share